CNS Pharmaceuticals, Inc. (CNSP)

Distributing

Institutional distribution: ownership decreased -2.09% quarter-over-quarter.

Data as of Q1 2026

Institutional Ownership

17.94%

QoQ Change

-2.09%

Total Value

$348.7M

Shares Outstanding

811K

Crowding AnalysisModerate

Holders11of 5,944

Avg: 68

Uncrowded71th percentileCrowded

Institutional Activity

Buy/Sell Ratio3x

39th percentile

6 buying2 selling

New

-2

Closed

+21K

Net shares

Holding Period Distribution

estimate

Median: 2 QAvg: 2 QHolders: 11

Ownership Concentration

Top 5: 99.5%Top 10: 100.0%

Stonepine Capital Management,41.9%

Ikarian Capital,31.5%

GEODE CAPITAL MANAGEMENT,15.9%

BOOTHBAY FUND MANAGEMENT,9.3%

Tower Research Capital LLC (TRC)0.9%

Others (6)0.5%

Loading crowding analysis...

Conviction-Weighted Ownership

Median weight: 0.00%Avg weight: 0.01%Max: 0.07%High conviction (>1%): 0

Stonepine Capital Management,

Ikarian Capital,

GEODE CAPITAL MANAGEMENT,

BOOTHBAY FUND MANAGEMENT,

Tower Research Capital LLC (TRC)

UBS Group AG

BARRETT & COMPANY,

MAI Capital Management

DANSKE BANK A/S

CITIGROUP

Loading conviction analysis...

Whale Moves Timeline (3 Quarters)

Biggest dollar-value position changes among top 10 holders

NEWGEODE CAPITAL MANAGEMENT$56K23K shr

BOUGHTStonepine Capital Management$29K12K shr

NEWTower Research Capital LLC (TRC)$3K1K shr

BOUGHTUBS Group AG$281118 shr

NEWCITIGROUP$21 shr

NEWStonepine Capital Management$256K49K shr

NEWIkarian Capital$241K46K shr

NEWBOOTHBAY FUND MANAGEMENT$71K14K shr

SOLDUBS Group AG$52K10K shr

BOUGHTDRW Securities$7K1K shr

Loading whale moves...

Institutional Trends (8 Quarters)

Loading ownership trends...

Institutional Holders

Loading top holders...